FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
What Is Low Testosterone & What Causes It?
Low testosterone or testosterone deficiency, also known as hypogonadism, is a condition in which patients develop symptoms.
Becker's Hospital Review54m
FDA rejects GLP-2 drug candidate
Zealand Pharma's GLP-2 drug candidate fails to gain FDA approval due to request for additional trial to confirm efficacy and safety.
McKnight's Long-Term Care News9h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).